P

Inventor

RUDOLPH RAINER

DE30 patents
⚠️ This page may combine multiple inventors who share the name “RUDOLPH RAINER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOEHRINGER MANNHEIM GMBH

17 patents
US5919757AJul 6, 1999

Aqueous pharmaceutical preparations of G-CSF with a long shelf life

BOEHRINGER MANNHEIM GMBH86 citations96
US5919443AJul 6, 1999

Stable lyophilized pharmaceutical preparations of G-CSF

BOEHRINGER MANNHEIM GMBH62 citations96
US5453363ASep 26, 1995

Process for the activation of t-PA or Ing after genetic expression in prokaryotes

BOEHRINGER MANNHEIM GMBH77 citations96
US5672691ASep 30, 1997

Recombinant core streptavidin

BOEHRINGER MANNHEIM GMBH34 citations92
US5593865AJan 14, 1997

Process for the activating of gene-technologically produced, heterologous, disulphide bridge-containing eukaryotic proteins after expression in prokaryotes

BOEHRINGER MANNHEIM GMBH33 citations92
US5489528AFeb 6, 1996

Recombinant core-streptavidin

BOEHRINGER MANNHEIM GMBH21 citations92
US5077392ADec 31, 1991

Process for activation of recombinant protein produced by prokaryotes

BOEHRINGER MANNHEIM GMBH38 citations92
US4933434AJun 12, 1990

Process for obtaining renatured proteins

BOEHRINGER MANNHEIM GMBH11 citations74
US5409699AApr 25, 1995

Compositions containing glycosylated molecules having human tissue type plasminogen activator enzymatic activity

BOEHRINGER MANNHEIM GMBH11 citations73
US5352452AOct 4, 1994

Stabilized compositions containing non-glysylated human tissue type plasminogen activator derivative K2P pro

BOEHRINGER MANNHEIM GMBH11 citations73
US5223256AJun 29, 1993

Thrombolytically active non-glycosylated protein

BOEHRINGER MANNHEIM GMBH14 citations73
US5618927AApr 8, 1997

Process for the reactivation of denatured protein

BOEHRINGER MANNHEIM GMBH6 citations71
US5578710ANov 26, 1996

Activation of recombinant proteins

BOEHRINGER MANNHEIM GMBH12 citations71
US5434067AJul 18, 1995

Process for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphatase

BOEHRINGER MANNHEIM GMBH12 citations71
US5352453AOct 4, 1994

Compositions containing non-glycosylated human tissue type plasminogen activator

BOEHRINGER MANNHEIM GMBH4 citations62
US5965424AOct 12, 1999

Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases

BOEHRINGER MANNHEIM GMBH5 citations60
US5854048ADec 29, 1998

Method for treating thromboembolic conditions using thrombolytically active proteins

BOEHRINGER MANNHEIM GMBH1 citations52

HOFFMANN LA ROCHE

3 patents

FIEDLER MARKUS

2 patents

RATTENHOLL ANKE

2 patents

SCIL PROTEINS GMBH

1 patent

(unassigned)

1 patent

FIEDLER ULRIKE

1 patent

BOSCH GMBH ROBERT

1 patent

ROCHE DIAGNOSTICS GMBH

1 patent

RUDOLPH RAINER

1 patent